Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MREO Mereo Biopharma Group Plc

Pre-Mkt 02-25 05:41:54 EST

0.3977

-0.0049

-1.22%

盘前0.3943

-0.0034-0.85%

05:29 EST

High0.4092	Low0.3928	Vol1.16M
Open0.3974	D1 Closing0.4026	Amplitude4.07%
Mkt Cap63.29M	Tradable Cap39.96M	Total Shares159.13M
T/O465.02K	T/O Rate1.16%	Tradable Shares100.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":0.3977,"timestamp":1771966800000,"preClose":0.4026,"halted":0,"volume":1161949,"hourTrading":{"tag":"盘前","latestPrice":0.3943,"preClose":0.3977,"latestTime":"05:29 EST","volume":585,"amount":230.6932992,"timestamp":1772015359866,"change":-0.0034,"changeRate":-0.008549,"amplitude":0.000251},"delay":0,"changeRate":-0.012170889220069587,"floatShares":100470459,"shares":159131700,"eps":-0.261249,"marketStatus":"Pre-Mkt","change":-0.0049,"latestTime":"02-25 05:41:54 EST","open":0.3974,"high":0.4092,"low":0.3928,"amount":465022.84240366,"amplitude":0.040735,"askPrice":0.4239,"askSize":100,"bidPrice":0.3942,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.261249,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772029800000},"marketStatusCode":1,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":0.3977,"preHourTrading":{"tag":"盘前","latestPrice":0.3943,"preClose":0.3977,"latestTime":"05:29 EST","volume":585,"amount":230.6932992,"timestamp":1772015359866,"change":-0.0034,"changeRate":-0.008549,"amplitude":0.000251},"postHourTrading":{"tag":"盘后","latestPrice":0.4022,"preClose":0.3977,"latestTime":"19:46 EST","volume":11339,"amount":4545.1856,"timestamp":1771980385972,"change":0.0045,"changeRate":0.011315,"amplitude":0.022127},"volumeRatio":0.3478118651747513,"impliedVol":0.0463,"impliedVolPercentile":0.048},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2614777060","title":"Critica drills into Jupiter as rare earths upgrade heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2614777060","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614777060?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:12","pubTimestamp":1771971179,"startTime":"0","endTime":"0","summary":"Critica Limited has kicked off resource upgrade aircore drilling at its flagship Jupiter rare earths project in WA’s Mid West, with the program results expected to be a core input to the ongoing scoping study. ","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-21752827/8e3b52ec51b020e64b95ad41cb8606b37addb253.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21752827/8e3b52ec51b020e64b95ad41cb8606b37addb253.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/public-companies/critica-drills-into-jupiter-as-rare-earths-upgrade-heats-up-c-21752827","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/public-companies/critica-drills-into-jupiter-as-rare-earths-upgrade-heats-up-c-21752827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["EIS","BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2614745647","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2614745647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614745647?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:03","pubTimestamp":1771948999,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% higher to 1,839.63 on the S&P Europe Select ADR Index.From continental Europe,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4521","LYG","NCNA","BK7142","BK4207","BK4020","IE00BFMHRM44.USD","DBVT","TELFY","IE00BMPRXR70.SGD","NVO","IE00BFXG1179.USD","NOK","IE00BKVL7J92.USD","BDRX","IE00BMPRXN33.USD","BK4532","TRIB","BK7062","NVOX","LU2543165471.USD","BK4585","BK4075","SAN","IE00BZ1G4Q59.USD","MREO","BK4599","BK4547","BK4009","NVOH","BK4115","LNOK","BK4139","BK4107","BK4117","AUTL","LU1093756325.SGD","AKTX","LU1093756168.USD","LU0006061336.USD","BK4505","BK4082","BTI","EVAX","SNY","LU0154236417.USD","BK7104","BK4007","CRTO"],"gpt_icon":1},{"id":"2613918754","title":"Mereo BioPharma Faces Securities Class Action as Lead Plaintiff Deadline Nears","url":"https://stock-news.laohu8.com/highlight/detail?id=2613918754","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613918754?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:18","pubTimestamp":1771895882,"startTime":"0","endTime":"0","summary":"A federal securities class action has been filed against Mereo BioPharma Group plc, with investors who bought or acquired the company’s securities between June 5, 2023 and December 26, 2025 reminded that the deadline to seek appointment as lead plaintiff is April 6, 2026. The complaint alleges the company and certain executives made false or misleading statements or failed to disclose the true status of the Phase 3 ORBIT and COSMIC programs for setrusumab, which later missed their primary endpoints; Mereo’s shares fell sharply after the trial results were announced.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL4PVl8d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2613730947","title":"Mereo BioPharma Faces Investor Lawsuit After Phase 3 Trial Failures Trigger Stock Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730947","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730947?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:28","pubTimestamp":1771882137,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has filed a securities lawsuit involving Mereo BioPharma Group plc, alleging the company misled investors about the prospects for its setrusumab program. The litigation points to sharp share-price drops after disclosures that the ORBIT and COSMIC Phase 3 studies did not achieve statistical significance, including an 87.7% plunge on Dec. 29, 2025. Investors have until April 6, 2026 to seek lead plaintiff status.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL5pfKQw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","NDAQ","SG9999014013.SGD","MREO","BK4505","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4588","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","BK4585","BK4112"],"gpt_icon":0},{"id":"2613100215","title":"Rosen Law Firm Urges Mereo BioPharma ADS Investors to Act Before April 6 Lead Plaintiff Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2613100215","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613100215?lang=en_us&edition=fundamental","pubTime":"2026-02-21 08:40","pubTimestamp":1771634440,"startTime":"0","endTime":"0","summary":"Rosen Law Firm has reminded investors of an April 6, 2026 deadline to seek lead-plaintiff status in a securities class action involving Mereo BioPharma Group plc. The suit covers purchases of the company’s American Depositary Shares between June 5, 2023 and Dec. 26, 2025, and alleges the company made materially misleading statements about expected Phase 3 ORBIT and COSMIC study results for setrusumab in osteogenesis imperfecta, after the trials allegedly failed to meet their primary endpoints.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260221:nNDL3TSYMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2613299569","title":"Schall Law Firm Files Securities Fraud Class Action Against Mereo BioPharma Group plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2613299569","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613299569?lang=en_us&edition=fundamental","pubTime":"2026-02-21 01:36","pubTimestamp":1771608979,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Mereo BioPharma Group plc in the U.S., alleging violations of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The suit claims the company made false and misleading statements during the period from June 5, 2023 to December 26, 2025 by concealing negative facts about its Phase 3 ORBIT and COSMIC programs, and later disclosed that neither program met its primary endpoint. Investors who bought shares during the class period are being urged to seek lead plaintiff status by April 6, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL8hyjXf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","MREO","LU0314104364.USD","BK4112","NDAQ","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014021.USD","BK4588","IE00B3QW5Z07.USD","SG9999014039.USD","BK4139","LU2095319765.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2612877285","title":"Mereo BioPharma Faces Securities Class Action Ahead of April 6, 2026 Lead Plaintiff Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612877285","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612877285?lang=en_us&edition=fundamental","pubTime":"2026-02-19 22:42","pubTimestamp":1771512143,"startTime":"0","endTime":"0","summary":"Faruqi and Faruqi has reminded investors of an April 6, 2026 deadline to seek lead-plaintiff status in a federal securities class action filed against Mereo BioPharma Group plc. The suit alleges the company and certain executives made false or misleading statements or failed to disclose problems with the Phase 3 ORBIT and COSMIC setrusumab trials, which later missed their primary endpoints; Mereo shares fell sharply after the results were announced in late December 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLVL52m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","BK4505","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014021.USD","MREO","BK4139","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","LU2095319765.USD","IE00BKPKM429.USD","BK4112","LU0314104364.USD","SG9999014039.USD","NDAQ"],"gpt_icon":0},{"id":"2612498276","title":"Mereo BioPharma Faces Nasdaq Delisting Risk Over Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2612498276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612498276?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:33","pubTimestamp":1771363998,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group plc has received a notice from Nasdaq after its American Depositary Shares  failed to maintain the minimum bid price of $1.00 for 30 consecutive business days, as required by Nasdaq Listing Rule 5550. The company has until August 17, 2026, to regain compliance or risk potential delisting, though its shares continue to trade for now.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mereo BioPharma Group plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL2BTZ0G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2612452178","title":"Mereo BioPharma Faces Shareholder Class Action Over Alleged Misstatements","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452178","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452178?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:05","pubTimestamp":1771333542,"startTime":"0","endTime":"0","summary":"A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc, alleging the company issued false and misleading statements and failed to disclose material adverse facts regarding its drug setrusumab's ability to achieve key clinical endpoints. Investors who purchased Mereo shares between June 5, 2023, and December 26, 2025, and experienced significant losses may seek to be appointed lead plaintiff by April 6, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL6VFcbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","SG9999014039.USD","IE00B64PRP62.GBP","BK4588","MREO","BK4505","BK4112","SG9999014005.SGD","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","BK4139","SG9999014013.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2612434223","title":"Viridis Mining and Minerals Says Drilling Strengthens Resource Confidence at Brazil Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2612434223","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612434223?lang=en_us&edition=fundamental","pubTime":"2026-02-17 13:52","pubTimestamp":1771307561,"startTime":"0","endTime":"0","summary":"Viridis Mining and Minerals  said drilling results from the Northern Concessions of its Colossus Project in Brazil support resource upgrade, development optionality, and growth strategy, according to a Tuesday Australian bourse filing.The results were of up to 12 metres at 6,082 parts per million  total rare earth oxide , including four metres at 10,520 ppm TREO, and 4,857 ppm magnet rare earth oxides .The results, which have targeted pit feed areas used in the pre-feasibility study , have delivered grades exceeding those previously modelled in the block model, supporting expectations of a \"significant\" feed-grade uplift in the upcoming resource update, and show opportunities for improvement in project economics.The company said that several project initiatives and studies are advancing in parallel to support engineering and processing workstreams, including geotechnical investigations and in-situ density determination.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK4195","BK4139","MREO","PFS","VMM.AU","BK4505","BK4211","BK4109","MTX"],"gpt_icon":0},{"id":"2611169974","title":"Mereo BioPharma Faces Class Action Over Failed Setrusumab Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169974","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611169974?lang=en_us&edition=fundamental","pubTime":"2026-02-14 00:14","pubTimestamp":1770999240,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against Mereo BioPharma Group plc on behalf of investors who purchased the company’s American Depositary Shares between June 5, 2023, and December 26, 2025. The complaint alleges that Mereo and certain executives made materially false and misleading statements regarding the likelihood of success of its Phase 3 clinical trials for setrusumab, a treatment for Osteogenesis Imperfecta. According to the lawsuit, the company repeatedly expressed confidence that its ORBIT and COSMIC trials would achieve statistical significance in reducing annualized fracture rates and position setrusumab for regulatory success, while concealing adverse facts about the studies’ progress. On December 29, 2025, Mereo disclosed that neither trial achieved its primary endpoint, leading to a sharp decline in its share price by over 87 percent. Investors have until April 6, 2026, to seek appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL2xzVHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","BK4505","MREO","LU2095319765.USD","BK4112","BK4585","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","BK4139","SG9999014039.USD"],"gpt_icon":0},{"id":"2611037973","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2611037973","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611037973?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:21","pubTimestamp":1770913314,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 1.22% to 1,824.99 on the S&P Europe Select ADR Index.From continental Europe, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","SNN","BDRX","LU0109394709.USD","IE00BJT1NW94.SGD","ARGX","BK4020","BK4158","BK4588","BK4204","BK4111","IE00BMPRXN33.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4139","BK4117","IE00BZ1G4Q59.USD","BK4599","BK4505","BK7104","PSO","IE00BFXG1179.USD","BK7119","EVAX","IE00B2B36J28.USD","BK4162","BK4009","BUD","BK4007","BK4023","BK4547","LU2324357040.USD","SNY","IE00BKVL7J92.USD","IE00BFMHRM44.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","AKTX","SLN","CRTO","BK4532","BK4082","BK4142","02378","IE0002141913.USD","MREO","LU0154236417.USD","IE00BMPRXR70.SGD","NOK","IE0009355771.USD","LU1093756168.USD","BK4585","IHG","LU1093756325.SGD","BK4107","OPRA","IE0034235188.USD","NVOH","PUK","LU1983260115.SGD","NVOX"],"gpt_icon":1},{"id":"2610954399","title":"European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2610954399","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610954399?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:04","pubTimestamp":1770825899,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were modestly higher late Wednesday morning, rising 0.19% to 1,836.99 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS  and petroleum refiner Equinor , which rose 2.1% and 1.8%, respectively. They were followed by consumer goods company Unilever  and telecommunications operator Telefonica , which were up 1.5% and 1.2%, respectively.The decliners from continental Europe were led by internet advertising firm Criteo  and semiconductor company Sequans Communications , which shed 13% and 7.7%, respectively. They were followed by biopharmaceutical companies DBV Technologies  and Cellectis , which fell 6.5% and 6.2%, respectively.From the UK and Ireland, the gainers were led by pharmaceutical company AstraZeneca  and oil and gas company BP , which advanced 3.5% and 3.3%, respectively. They were followed by biopharmaceutical company Akari Therapeutics  and utiliti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WPP.AU","LU0689626769.HKD","BK4585","ULVR.UK","AZN","BK4505","BK4201","BK4592","LU0109394709.USD","LU1162221912.USD","BK4115","EQNR","LU2462157665.USD","WPP","BCYC","BK4141","BK4208","LU0124676726.USD","LU0320765992.SGD","DBVT","BK4532","LU1829250122.USD","LU2236285917.USD","BK4107","TELFY","LU0072461881.USD","BK4183","CLLS","CRTO","BK4117","LU2456880835.USD","UL","AKTX","BK4082","BK4009","BK4588","IE00BFMHRM44.USD","LU0889565916.HKD","EDAP","SQNS","BK4139","NGG","TRIB","BK4007","AFG","BP","LU0320765646.SGD","UN","LU2417539215.USD","MREO"],"gpt_icon":0},{"id":"2610652859","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2610652859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610652859?lang=en_us&edition=fundamental","pubTime":"2026-02-10 00:12","pubTimestamp":1770653557,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.40% to 1,829.22 on the S&P Europe Select ADR Index.From continental Eu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UL","BK7104","BK7511","BK4009","LU0300736492.USD","CRTO","BK4592","BK4599","DAVA","IE00BKVL7J92.USD","LU0648005311.SGD","BK4139","BK4528","BK4532","SLN","LU0689626769.HKD","BK4168","BK4141","NVOX","UN","IE00BFMHRM44.USD","LU0320765646.SGD","AKTX","BK4588","LU1093756325.SGD","PHG","BK4201","BK7507","BK4207","LYG","LU0300736062.USD","BK4082","BHP","ULVR.UK","EDAP","LU1162221912.USD","SAP","NVO","LU0154236417.USD","LU0098860793.USD","IE00BZ1G4Q59.USD","LU0278409577.USD","CLLS","BK4117","BK4023","LU1093756168.USD","NVOH","MREO","BK7095","BK4007","BK4107","BK4613","LU2236285917.USD","BDRX","BK4183","BK4505","BK4134","LU0084288595.USD","BK4521","SQNS","BK4585","LU0124676726.USD","SHEL"],"gpt_icon":0},{"id":"2608803179","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2608803179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608803179?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:10","pubTimestamp":1770135009,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.17% to 1,828.18 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical company DBV Technologies , which climbed 7.1% and 5.2% respectively. They were followed by biopharmaceutical company argenx  and lender ING , which advanced 2% and 1.6% respectively.The decliners from continental Europe were led by internet browser company Opera  and software firm SAP , which dropped 7.3% and 4.2% respectively. They were followed by biopharmaceutical company Cellectis  and 3D printer company Materialise , which lost 2.3% and 1.8% respectively.From the UK and Ireland, the gainers were led by mining company BHP Group  and biopharmaceutical company Mereo BioPharma Group , which rose 4.8% and 4.1% respectively. They were followed by biotech firm Autolus Therapeutics  and telecommunications operator Vodafone Group","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DBVT","BK7505","EVAX","WPP","LU0084288595.USD","OPRA","AUTL","ING","ARGX","BHP.AU","BK4528","BCYC","ING.AU","BK4134","IE00BFTCPJ56.SGD","VOD","DAVA.AU","BK4132","DAVA","WPP.AU","SAP","IE00BJJMRZ35.SGD","MREO","BK4204","BK4009","PSO","LU2324357040.USD","AFG","BK4585","BK4546","BK4107","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","BK4613","BHP","IE00B4R5TH58.HKD","LU1983260115.SGD","LU0320765992.SGD","IE0034235188.USD","BK7511","LU0648005311.SGD","LU0889565916.HKD","BK7507","MTLS","IE0002141913.USD","CLLS","IE00B2B36J28.USD","BK4168","BK7095"],"gpt_icon":0},{"id":"2608893003","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2608893003","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608893003?lang=en_us&edition=fundamental","pubTime":"2026-02-03 00:09","pubTimestamp":1770048544,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week higher, rising 0.8% late Monday morning to 1,824.45 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and furniture maker Natuzzi , which climbed 16.1% and 8.1% respectively. They were followed by biopharmaceutical company DBV Technologies  and software firm SAP , which advanced 3% and 2.3% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and biotech firm BioNTech , which dropped 7.2% and 3.8% respectively. They were followed by petroleum refiner Equinor  and pharmaceutical company Novo Nordisk , which lost 3.4% and 1.1% respectively.From the UK and Ireland, the gainers were led by cruise line operator Carnival , which rose 5.4%, followed by hospitality company InterContinental Hotels Group  and software firm Endava , which gained 2.5% each, and biotech company Trinity Biotech , w","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BNTX","BK4599","BK4505","IHG","BK4535","BK4548","LU1093756325.SGD","BK4023","DAVA","IE00BZ1G4Q59.USD","LU0154236417.USD","SQNS","BK7104","BK4169","DBVT","BK4201","BK4585","IE00BKVL7J92.USD","BK4095","DGE.UK","EQNR","LU0084288595.USD","BK4141","MREO","OPRA","SAP","BK4568","BK4009","BK4134","BDRX","LU0648005311.SGD","BK4139","WPP","BK4107","NTZ","LU1093756168.USD","BK4613","CUK","BK4559","BK4532","BK4588","TRIB","DEO","BK4142","BK4117","BK4082","BK4551","BK4528"],"gpt_icon":1},{"id":"2607187037","title":"Update: European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2607187037","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607187037?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:26","pubTimestamp":1769707581,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down late Thursday morning, declining 0.82% to 1,802.03 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor , which rose 1.9%. They were followed by brewing company Anheuser-Busch InBev  and oil and gas company Eni , which were up 1.5% and 1.2% respectively.The decliners from continental Europe were led by software firm SAP  and telecommunications company Nokia , which dropped 17% and 9.3% respectively. They were followed by semiconductor company Sequans Communications  and internet browser company Opera , which lost 8.3% and 4.4% respectively.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and mining company BHP Group , which advanced 7% and 2.1% respectively. They were followed by oil and gas company Shell  and pharmaceutical company GSK , which increased 1.9% and 1.8% respectively.The decliners from the UK and Ireland were ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EQNR","SAP","NOK","TRIB","CUK","E","BK4107","LU0300736492.USD","BHP","BK4158","NCNA","BK7119","SQNS","BK4532","LU0278409577.USD","IE00BMPRXN33.USD","GSK","BK4613","OPRA","SHEL","BK4168","LU2236285917.USD","BK4585","MREO","IE00BMPRXR70.SGD","GSK.UK","LU0320765646.SGD","LU1829250122.USD","BDRX","BK4139","BK4007","BUD","BUD.AU","BK4023","LU0098860793.USD","LU0300736062.USD","BK4528","BK4082","BK7507","BK4020","AFG","BK7095","BK4117","BK4588","LU1162221912.USD","BHP.AU","BK4505","BK4142","BK4547"],"gpt_icon":0},{"id":"2607323745","title":"European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2607323745","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607323745?lang=en_us&edition=fundamental","pubTime":"2026-01-29 00:16","pubTimestamp":1769616962,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell sharply late Wednesday morning, dropping 1.35% to 1,820.75 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera  and accommodations booking site trivago , which rose 4.1% and 0.7% respectively. They were followed by software firm SAP  and internet advertising firm Criteo , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and pharmaceutical company Ascendis Pharma , which fell 4% and 3.8% respectively. They were followed by biotech firm Evaxion  and lender Banco Bilbao Vizcaya Argentaria , which were down 3.7% and 3.4% respectively.From the UK and Ireland, the gainers were led by insurance firm Prudential  and alcoholic beverage company Diageo , which advanced 1.4% and 0.9%, respectively. They were followed by educational publisher Pearson , which increased 0.7%.The decliners f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRA","TRVG","EVAX","MREO","PSO","BBVA","BK4139","LU0320765992.SGD","BK4169","BK4207","BK4505","BK4107","BK4077","BK4204","BK4588","BK4613","SAP","DEO","BDRX","DGE.UK","ASND","BK4162","TRIB","BK4023","BK4528","BCYC","LU0109394709.USD","IE00BFMHRM44.USD","CLLS","BK4082","PUK","BK4009","BK4585","AFG","BK4111","CRTO","LU0889565916.HKD","BK4117","BK4559"],"gpt_icon":0},{"id":"2606244194","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2606244194","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606244194?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:06","pubTimestamp":1769443590,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week sharply higher late Monday morning, rising 1.21% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and software firm SAP , which rose 2.4% and 2.1%, respectively. They were followed by lender Banco Santander  and telecommunications company Ericsson , which were up 2% and 1.8%, respectively.The decliners from continental Europe were led by biopharmaceutical companies Cellectis  and DBV Technologies , which fell 6.4% and 3.1%, respectively. They were followed by semiconductor company Sequans Communications  and pharmaceutical company Ascendis Pharma , which were down 2.8% and 0.9%, respectively.From the UK and Ireland, the gainers were led by mining company BHP Group  and utilities company National Grid , which advanced 2.1% and 1.8%, respectively. They were followed by pharmaceutical company GSK  and lender Lloyds Banking ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMRN","LU0109394709.USD","BK7104","BK7511","LU0300736492.USD","BK4599","IE00BKVL7J92.USD","BK4139","BK4528","BK4532","LU1829250122.USD","TRIB","BK4168","ERIC","BK4141","BK4591","LU0889565916.HKD","DBVT","LU1093756325.SGD","NGG","BK4588","BK7507","BK4207","LYG","LU0300736062.USD","BK4082","BHP","GSK.UK","SAP","NVO","ASND","LU0154236417.USD","AUTL","IE00BZ1G4Q59.USD","CLLS","BK4117","BK4023","BK7142","LU1093756168.USD","MREO","BK4208","BK4515","BK4007","BK7095","BK4107","BK4554","LU0320765992.SGD","BK4020","BK4613","BK4505","BK4521","GSK","SQNS","BK4585","SAN"],"gpt_icon":1},{"id":"2605429578","title":"Dalaroo launches exploration blitz on epic Greenland rare earths play","url":"https://stock-news.laohu8.com/highlight/detail?id=2605429578","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605429578?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:05","pubTimestamp":1769119552,"startTime":"0","endTime":"0","summary":"Dalaroo Metals is charging ahead with a high-octane 2026 exploration blitz at its flagship Blue Lagoon critical minerals project in Greenland, hot on the heels of a knockout reconnaissance program in 2025.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-21399938/99bc18ffc327961802e48b1b751407723c0ed76f.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21399938/99bc18ffc327961802e48b1b751407723c0ed76f.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-launches-exploration-blitz-on-epic-greenland-rare-earths-play-c-21399938","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/dalaroo-launches-exploration-blitz-on-epic-greenland-rare-earths-play-c-21399938","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.2455},{"period":"3month","weight":-0.7839},{"period":"6month","weight":-0.7727},{"period":"1year","weight":-0.8522},{"period":"ytd","weight":-0.0456}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.015037},{"month":2,"riseRate":0.428571,"avgChangeRate":0.019253},{"month":3,"riseRate":0,"avgChangeRate":-0.177922},{"month":4,"riseRate":0.666667,"avgChangeRate":0.141069},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.12077},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001557}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}